The Impact of Substantial Improvements in HbA1c and Weight Loss on the Medication Preferences of People with Type 2 Diabetes

PURPOSE: To quantify the preferences of people with type 2 diabetes (T2D) for treatment attributes of a glucose-dependent insulinotropic polypeptide (GIP)/glucagon-like peptide-1 (GLP-1) receptor agonist (RA) versus an injectable GLP-1 RA medication profile. PATIENTS AND METHODS: Injection-naive peo...

Descripción completa

Detalles Bibliográficos
Autores principales: Gelhorn, Heather L, Osumili, Beatrice, Brown, Katelyn, Ross, Melissa M, Schulz, Andrea, Fernandez, Gabriela, Boye, Kristina S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040168/
https://www.ncbi.nlm.nih.gov/pubmed/36987498
http://dx.doi.org/10.2147/PPA.S401465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040168/
https://www.ncbi.nlm.nih.gov/pubmed/36987498
http://dx.doi.org/10.2147/PPA.S401465

Ejemplares similares